ICGC-ARGO precision medicine: familial matters in pancreatic cancer
ICGC-ARGO precision medicine: familial matters in pancreatic cancer
About this item
Full title
Author / Creator
Publisher
England: Elsevier Ltd
Journal title
Language
English
Formats
Publication information
Publisher
England: Elsevier Ltd
Subjects
More information
Scope and Contents
Contents
Precision Medicine Tumour Board recommendation On the basis of somatic and germline molecular profiling (table and appendix pp 2–3), the board recommended screening for enrolment in a phase 1 trial with a second-generation poly(ADP-ribose)polymerase (PARP) inhibitor (NCT04182516); rechallenge with platinum-based regimens gemcitabine plus nab-paclit...
Alternative Titles
Full title
ICGC-ARGO precision medicine: familial matters in pancreatic cancer
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_journals_2615288960
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_2615288960
Other Identifiers
ISSN
1470-2045
E-ISSN
1474-5488
DOI
10.1016/S1470-2045(21)00703-8
